Veeva Systems (VEEV) 10-K Summary — Year Ended Jan 31, 2025
Veeva Systems provides cloud-based software and data solutions specifically for the global life sciences industry. The company reported strong financial performance with revenue, operating income, net income, and operating cash flow all showing positive results for the latest fiscal year.
Key takeaway
Year ended Jan 31, 2025 · FY2026 10-K
Veeva Systems provides cloud-based software and data solutions specifically for the global life sciences industry. The company reported strong financial performance with revenue, operating income, net income, and operating cash flow all showing positive results for the latest fiscal year.
Financial snapshot
Selected annual figures reported with the filing, shown separately from the narrative summary.
Annual revenue
$2.7B
Revenue reported for the fiscal year.
Operating income
$691.4M
Income from operations reported for the year.
Net income
$714.1M
Net income reported for the year.
Operating cash flow
$1.1B
Cash generated by operating activities.
Annual revenue trend
Reported annual revenue and its change from the preceding fiscal year.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jan 31, 2022 | $1.9B | n/a |
| Jan 31, 2023 | $2.2B | +16.4% |
| Jan 31, 2024 | $2.4B | +9.7% |
| Jan 31, 2025 | $2.7B | +16.2% |
Business overview
Veeva Systems operates as a provider of cloud applications and data services tailored for the life sciences sector, including pharmaceutical, biotechnology, and medical device companies. The company's business overview outlines its focus on helping customers manage critical functions such as research and development, clinical trials, regulatory compliance, and commercial operations. The filing indicates that Veeva's offerings are designed to address the unique regulatory and operational needs of the life sciences industry.
Financial performance
Revenue reached a reported level, showing growth compared to the prior fiscal year. Operating income, net income, and operating cash flow were each at reported amounts, reflecting profitability and positive cash generation. The trend data shows revenue has increased over several consecutive periods.
Material risks
The filing highlights that Veeva operates in a highly competitive market for cloud software in the life sciences industry. The company's success depends on maintaining and expanding its customer relationships and adapting to evolving regulatory standards. Additionally, risks include potential cybersecurity threats and the need to manage technological changes to protect its software platform.
Liquidity and capital
The company reported positive operating cash flow, which it uses to fund its operations and investments. The liquidity section discusses that Veeva has sufficient resources to meet its short-term obligations and support ongoing business activities.
What to watch
Monitor how the company sustains its revenue growth rate and profitability in a competitive life sciences software market.